APO Research
Talk to an analyst

APO RESEARCH · REPORT

Finasteride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Finasteride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchFinasteride Tablets Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Finasteride Tablets Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Finasteride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Finasteride Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Finasteride Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Finasteride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Finasteride Tablets include Accord Pharmaceuticals, Actavis, Cipla, Dr. Reddy, RelonChem, Guangdong Eashu Pharmacetical, Henan Topfond, Zhejiang CONBA Pharmaceutical and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Finasteride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Finasteride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Finasteride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Finasteride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Finasteride Tablets Segment by Company

Accord Pharmaceuticals

Actavis

Cipla

Dr. Reddy

RelonChem

Guangdong Eashu Pharmacetical

Henan Topfond

Zhejiang CONBA Pharmaceutical

Merck

Shandong Renhetang Pharmaceutical

Sandoz

Teva Pharmaceuticals

Finasteride Tablets Segment by Type

1mg Tablet

5mg Tablet

Finasteride Tablets Segment by Application

Benign Prostatic Hyperplasia

Male Pattern Baldness

Others

Finasteride Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Finasteride Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Finasteride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Finasteride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Finasteride Tablets Industry Trends Table 2. Finasteride Tablets Industry Drivers Table 3. Finasteride Tablets Industry Opportunities and Challenges Table 4. Finasteride Tablets Industry Restraints Table 5. Global Finasteride Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Finasteride Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Finasteride Tablets Sales by Manufacturers (W Pcs) & (2021-2026) Table 8. Global Finasteride Tablets Sales Market Share by Manufacturers Table 9. Global Finasteride Tablets Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Finasteride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Finasteride Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Finasteride Tablets Manufacturers, Product Type & Application Table 13. Global Finasteride Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Finasteride Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1mg Tablet Table 17. Major Manufacturers of 5mg Tablet Table 18. Global Finasteride Tablets Sales by Type 2021 VS 2025 VS 2032 (W Pcs) Table 19. Global Finasteride Tablets Sales by Type (2021-2026) & (W Pcs) Table 20. Global Finasteride Tablets Sales by Type (2027-2032) & (W Pcs) Table 21. Global Finasteride Tablets Sales Market Share by Type (2021-2026) Table 22. Global Finasteride Tablets Sales Market Share by Type (2027-2032) Table 23. Global Finasteride Tablets Revenue by Type 2021 VS 2025 VS 2032 (W Pcs) Table 24. Global Finasteride Tablets Revenue by Type (2021-2026) & (W Pcs) Table 25. Global Finasteride Tablets Revenue by Type (2027-2032) & (W Pcs) Table 26. Global Finasteride Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Finasteride Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Benign Prostatic Hyperplasia Table 29. Major Manufacturers of Male Pattern Baldness Table 30. Major Manufacturers of Others Table 31. Global Finasteride Tablets Sales by Application 2021 VS 2025 VS 2032 (W Pcs) Table 32. Global Finasteride Tablets Sales by Application (2021-2026) & (W Pcs) Table 33. Global Finasteride Tablets Sales by Application (2027-2032) & (W Pcs) Table 34. Global Finasteride Tablets Sales Market Share by Application (2021-2026) Table 35. Global Finasteride Tablets Sales Market Share by Application (2027-2032) Table 36. Global Finasteride Tablets Revenue by Application 2021 VS 2025 VS 2032 (W Pcs) Table 37. Global Finasteride Tablets Revenue by Application (2021-2026) & (W Pcs) Table 38. Global Finasteride Tablets Revenue by Application (2027-2032) & (W Pcs) Table 39. Global Finasteride Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Finasteride Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Finasteride Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 42. Global Finasteride Tablets Sales by Region (2021-2026) & (W Pcs) Table 43. Global Finasteride Tablets Sales Market Share by Region (2021-2026) Table 44. Global Finasteride Tablets Sales Forecasted by Region (2027-2032) & (W Pcs) Table 45. Global Finasteride Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 47. North America Finasteride Tablets Sales by Country (2021-2026) & (W Pcs) Table 48. North America Finasteride Tablets Sales by Country (2027-2032) & (W Pcs) Table 49. Europe Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 50. Europe Finasteride Tablets Sales by Country (2021-2026) & (W Pcs) Table 51. Europe Finasteride Tablets Sales by Country (2027-2032) & (W Pcs) Table 52. Asia Pacific Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 53. Asia Pacific Finasteride Tablets Sales by Country (2021-2026) & (W Pcs) Table 54. Asia Pacific Finasteride Tablets Sales by Country (2027-2032) & (W Pcs) Table 55. South America, Middle East and Africa Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 56. South America, Middle East and Africa Finasteride Tablets Sales by Country (2021-2026) & (W Pcs) Table 57. South America, Middle East and Africa Finasteride Tablets Sales by Country (2027-2032) & (W Pcs) Table 58. Global Finasteride Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Finasteride Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Finasteride Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Finasteride Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Finasteride Tablets Revenue Market Share by Region (2027-2032) Table 63. Accord Pharmaceuticals Company Information Table 64. Accord Pharmaceuticals Business Overview Table 65. Accord Pharmaceuticals Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Accord Pharmaceuticals Finasteride Tablets Product Portfolio Table 67. Accord Pharmaceuticals Recent Development Table 68. Actavis Company Information Table 69. Actavis Business Overview Table 70. Actavis Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Actavis Finasteride Tablets Product Portfolio Table 72. Actavis Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cipla Finasteride Tablets Product Portfolio Table 77. Cipla Recent Development Table 78. Dr. Reddy Company Information Table 79. Dr. Reddy Business Overview Table 80. Dr. Reddy Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dr. Reddy Finasteride Tablets Product Portfolio Table 82. Dr. Reddy Recent Development Table 83. RelonChem Company Information Table 84. RelonChem Business Overview Table 85. RelonChem Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. RelonChem Finasteride Tablets Product Portfolio Table 87. RelonChem Recent Development Table 88. Guangdong Eashu Pharmacetical Company Information Table 89. Guangdong Eashu Pharmacetical Business Overview Table 90. Guangdong Eashu Pharmacetical Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio Table 92. Guangdong Eashu Pharmacetical Recent Development Table 93. Henan Topfond Company Information Table 94. Henan Topfond Business Overview Table 95. Henan Topfond Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Henan Topfond Finasteride Tablets Product Portfolio Table 97. Henan Topfond Recent Development Table 98. Zhejiang CONBA Pharmaceutical Company Information Table 99. Zhejiang CONBA Pharmaceutical Business Overview Table 100. Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio Table 102. Zhejiang CONBA Pharmaceutical Recent Development Table 103. Merck Company Information Table 104. Merck Business Overview Table 105. Merck Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Merck Finasteride Tablets Product Portfolio Table 107. Merck Recent Development Table 108. Shandong Renhetang Pharmaceutical Company Information Table 109. Shandong Renhetang Pharmaceutical Business Overview Table 110. Shandong Renhetang Pharmaceutical Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio Table 112. Shandong Renhetang Pharmaceutical Recent Development Table 113. Sandoz Company Information Table 114. Sandoz Business Overview Table 115. Sandoz Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sandoz Finasteride Tablets Product Portfolio Table 117. Sandoz Recent Development Table 118. Teva Pharmaceuticals Company Information Table 119. Teva Pharmaceuticals Business Overview Table 120. Teva Pharmaceuticals Finasteride Tablets Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Teva Pharmaceuticals Finasteride Tablets Product Portfolio Table 122. Teva Pharmaceuticals Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Finasteride Tablets Distributors List Table 126. Finasteride Tablets Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Finasteride Tablets Product Image Figure 2. Global Finasteride Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Finasteride Tablets Sales (2021-2032) & (W Pcs) Figure 5. Global Finasteride Tablets Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Finasteride Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1mg Tablet Image Figure 9. 5mg Tablet Image Figure 10. Global Finasteride Tablets Sales by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 11. Global Finasteride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Finasteride Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Finasteride Tablets Revenue by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 14. Global Finasteride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Finasteride Tablets Revenue Market Share by Type (2021-2032) Figure 16. Benign Prostatic Hyperplasia Image Figure 17. Male Pattern Baldness Image Figure 18. Others Image Figure 19. Global Finasteride Tablets Sales by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 20. Global Finasteride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Finasteride Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Finasteride Tablets Revenue by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 23. Global Finasteride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Finasteride Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 26. North America Finasteride Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 28. Canada Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 29. Mexico Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 30. Europe Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 31. Europe Finasteride Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 33. France Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 34. U.K. Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 35. Italy Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 36. Netherlands Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 37. Asia Pacific Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 38. Asia Pacific Finasteride Tablets Sales Market Share by Country (2021-2032) Figure 39. China Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 40. Japan Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 41. South Korea Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 42. Southeast Asia Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 43. India Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 44. Australia Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 45. South America, Middle East and Africa Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 46. South America, Middle East and Africa Finasteride Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 48. South Africa Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 49. Saudi Arabia Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 50. Turkey Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 51. Argentina Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 52. UAE Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 53. Egypt Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 54. Chile Finasteride Tablets Sales and Growth Rate (2021-2032) & (W Pcs) Figure 55. Global Finasteride Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Finasteride Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Finasteride Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Finasteride Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Finasteride Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Finasteride Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Finasteride Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Finasteride Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg Tablet
  • 5mg Tablet
Applications
  • Benign Prostatic Hyperplasia
  • Male Pattern Baldness
  • Others
Companies covered
  • Accord Pharmaceuticals
  • Actavis
  • Cipla
  • Dr. Reddy
  • RelonChem
  • Guangdong Eashu Pharmacetical
  • Henan Topfond
  • Zhejiang CONBA Pharmaceutical
  • Merck
  • Shandong Renhetang Pharmaceutical
  • Sandoz
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Finasteride Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Finasteride Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Finasteride Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Finasteride Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Finasteride Tablets Market Dynamics
  1. 2.1 Finasteride Tablets Industry Trends
  2. 2.2 Finasteride Tablets Industry Drivers
  3. 2.3 Finasteride Tablets Industry Opportunities and Challenges
  4. 2.4 Finasteride Tablets Industry Restraints
3 Finasteride Tablets Market by Manufacturers
  1. 3.1 Global Finasteride Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Finasteride Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Finasteride Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Finasteride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Finasteride Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Finasteride Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Finasteride Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Finasteride Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Finasteride Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Finasteride Tablets Tier 1, Tier 2, and Tier 3
4 Finasteride Tablets Market by Type
  1. 4.1 Finasteride Tablets Type Introduction
  2. 4.1.1 1mg Tablet
  3. 4.1.2 5mg Tablet
  4. 4.2 Global Finasteride Tablets Sales by Type
  5. 4.2.1 Global Finasteride Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Finasteride Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Finasteride Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Finasteride Tablets Revenue by Type
  9. 4.3.1 Global Finasteride Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Finasteride Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Finasteride Tablets Revenue Market Share by Type (2021-2032)
5 Finasteride Tablets Market by Application
  1. 5.1 Finasteride Tablets Application Introduction
  2. 5.1.1 Benign Prostatic Hyperplasia
  3. 5.1.2 Male Pattern Baldness
  4. 5.1.3 Others
  5. 5.2 Global Finasteride Tablets Sales by Application
  6. 5.2.1 Global Finasteride Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Finasteride Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Finasteride Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Finasteride Tablets Revenue by Application
  10. 5.3.1 Global Finasteride Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Finasteride Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Finasteride Tablets Revenue Market Share by Application (2021-2032)
6 Global Finasteride Tablets Sales by Region
  1. 6.1 Global Finasteride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Finasteride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Finasteride Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Finasteride Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Finasteride Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Finasteride Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Finasteride Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Finasteride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Finasteride Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Finasteride Tablets Revenue by Region
  1. 7.1 Global Finasteride Tablets Revenue by Region
  2. 7.1.1 Global Finasteride Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Finasteride Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Finasteride Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Finasteride Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Finasteride Tablets Revenue (2021-2032)
  8. 7.2.2 North America Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Finasteride Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Finasteride Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Finasteride Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Finasteride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Pharmaceuticals
  2. 8.1.1 Accord Pharmaceuticals Company Information
  3. 8.1.2 Accord Pharmaceuticals Business Overview
  4. 8.1.3 Accord Pharmaceuticals Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Pharmaceuticals Finasteride Tablets Product Portfolio
  6. 8.1.5 Accord Pharmaceuticals Recent Developments
  7. 8.2 Actavis
  8. 8.2.1 Actavis Company Information
  9. 8.2.2 Actavis Business Overview
  10. 8.2.3 Actavis Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Actavis Finasteride Tablets Product Portfolio
  12. 8.2.5 Actavis Recent Developments
  13. 8.3 Cipla
  14. 8.3.1 Cipla Company Information
  15. 8.3.2 Cipla Business Overview
  16. 8.3.3 Cipla Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cipla Finasteride Tablets Product Portfolio
  18. 8.3.5 Cipla Recent Developments
  19. 8.4 Dr. Reddy
  20. 8.4.1 Dr. Reddy Company Information
  21. 8.4.2 Dr. Reddy Business Overview
  22. 8.4.3 Dr. Reddy Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dr. Reddy Finasteride Tablets Product Portfolio
  24. 8.4.5 Dr. Reddy Recent Developments
  25. 8.5 RelonChem
  26. 8.5.1 RelonChem Company Information
  27. 8.5.2 RelonChem Business Overview
  28. 8.5.3 RelonChem Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 RelonChem Finasteride Tablets Product Portfolio
  30. 8.5.5 RelonChem Recent Developments
  31. 8.6 Guangdong Eashu Pharmacetical
  32. 8.6.1 Guangdong Eashu Pharmacetical Company Information
  33. 8.6.2 Guangdong Eashu Pharmacetical Business Overview
  34. 8.6.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio
  36. 8.6.5 Guangdong Eashu Pharmacetical Recent Developments
  37. 8.7 Henan Topfond
  38. 8.7.1 Henan Topfond Company Information
  39. 8.7.2 Henan Topfond Business Overview
  40. 8.7.3 Henan Topfond Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Henan Topfond Finasteride Tablets Product Portfolio
  42. 8.7.5 Henan Topfond Recent Developments
  43. 8.8 Zhejiang CONBA Pharmaceutical
  44. 8.8.1 Zhejiang CONBA Pharmaceutical Company Information
  45. 8.8.2 Zhejiang CONBA Pharmaceutical Business Overview
  46. 8.8.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio
  48. 8.8.5 Zhejiang CONBA Pharmaceutical Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Finasteride Tablets Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Shandong Renhetang Pharmaceutical
  56. 8.10.1 Shandong Renhetang Pharmaceutical Company Information
  57. 8.10.2 Shandong Renhetang Pharmaceutical Business Overview
  58. 8.10.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio
  60. 8.10.5 Shandong Renhetang Pharmaceutical Recent Developments
  61. 8.11 Sandoz
  62. 8.11.1 Sandoz Company Information
  63. 8.11.2 Sandoz Business Overview
  64. 8.11.3 Sandoz Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sandoz Finasteride Tablets Product Portfolio
  66. 8.11.5 Sandoz Recent Developments
  67. 8.12 Teva Pharmaceuticals
  68. 8.12.1 Teva Pharmaceuticals Company Information
  69. 8.12.2 Teva Pharmaceuticals Business Overview
  70. 8.12.3 Teva Pharmaceuticals Finasteride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharmaceuticals Finasteride Tablets Product Portfolio
  72. 8.12.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Finasteride Tablets Value Chain Analysis
  2. 9.1.1 Finasteride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Finasteride Tablets Production Mode & Process
  6. 9.2 Finasteride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Finasteride Tablets Distributors
  9. 9.2.3 Finasteride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst